Laura Cebrián

637 total citations
26 papers, 370 citations indexed

About

Laura Cebrián is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Laura Cebrián has authored 26 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 11 papers in Pharmacology and 8 papers in Epidemiology. Recurrent topics in Laura Cebrián's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Salmonella and Campylobacter epidemiology (5 papers). Laura Cebrián is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Salmonella and Campylobacter epidemiology (5 papers). Laura Cebrián collaborates with scholars based in Spain. Laura Cebrián's co-authors include Juan Carlos Rodrı́guez, Gloria Royo, Carlos Mirete, Mar Masiá, A. Hidalgo, Félix Gutiérrez, Isabel Escribano, J. M. Sharp, M. De las Heras and Lluís Ferrer and has published in prestigious journals such as Clinical Infectious Diseases, Annals of the Rheumatic Diseases and International Journal of Antimicrobial Agents.

In The Last Decade

Laura Cebrián

25 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Cebrián Spain 10 230 84 58 50 41 26 370
Mary Jo Waters Australia 11 82 0.4× 103 1.2× 39 0.7× 17 0.3× 26 0.6× 17 263
Pilar Marín‐Casanova Spain 9 238 1.0× 95 1.1× 35 0.6× 11 0.2× 44 1.1× 16 384
A. Avlami Greece 11 162 0.7× 133 1.6× 14 0.2× 44 0.9× 45 1.1× 23 444
Constantin Hays France 13 169 0.7× 119 1.4× 53 0.9× 15 0.3× 33 0.8× 16 457
A.-M. Van den Abeele Belgium 11 229 1.0× 37 0.4× 86 1.5× 15 0.3× 12 0.3× 15 364
Elsebeth Tvenstrup Jensen Denmark 10 101 0.4× 35 0.4× 48 0.8× 26 0.5× 31 0.8× 16 346
Nils Olav Hermansen Norway 9 107 0.5× 213 2.5× 42 0.7× 40 0.8× 29 0.7× 18 539
A. Marrón Spain 6 160 0.7× 39 0.5× 13 0.2× 42 0.8× 23 0.6× 9 315
Gülşen­ Hazırolan Türkiye 9 108 0.5× 90 1.1× 22 0.4× 21 0.4× 28 0.7× 71 296
Canan Külah Türkiye 16 174 0.8× 220 2.6× 26 0.4× 28 0.6× 84 2.0× 37 582

Countries citing papers authored by Laura Cebrián

Since Specialization
Citations

This map shows the geographic impact of Laura Cebrián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cebrián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cebrián more than expected).

Fields of papers citing papers by Laura Cebrián

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Cebrián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cebrián. The network helps show where Laura Cebrián may publish in the future.

Co-authorship network of co-authors of Laura Cebrián

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Cebrián. A scholar is included among the top collaborators of Laura Cebrián based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Cebrián. Laura Cebrián is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brañas, Fátima, et al.. (2018). Beyond orthogeriatric co-management model: benefits of implementing a process management system for hip fracture. Archives of Osteoporosis. 13(1). 81–81. 7 indexed citations
2.
Muñoz‐Fernández, Santiago, et al.. (2017). SCORE study: quality indicators for rheumatology nursing clinics. Rheumatology International. 37(3). 353–361. 5 indexed citations
3.
Cebrián, Laura, et al.. (2008). Evaluation of the in-vitro cidal activity and toxicity of a novel peroxygen biocide: 2-butanone peroxide. Journal of Hospital Infection. 68(3). 248–254. 4 indexed citations
5.
Cebrián, Laura, et al.. (2006). Actividad de cefpodoxima y otros betalactámicos orales frente a Haemophilus influenzae y Streptococcus pneumoniae con distinta sensibilidad a la penicilina. Revista española de quimioterapia. Suplemento. 19(1). 39–44. 3 indexed citations
6.
Cebrián, Laura, et al.. (2006). Disminución de la actividad bactericida del ciprofloxacino en mutantes de Salmonella generados tras exposición repetida a diversas fluoroquinolonas. Hispana. 19(4). 363–366. 1 indexed citations
7.
Escribano, Isabel, et al.. (2006). Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp.. Journal of Infection and Chemotherapy. 12(4). 177–180. 4 indexed citations
8.
Cebrián, Laura, Juan Carlos Rodrı́guez, Isabel Escribano, & Gloria Royo. (2006). Effect of exposure to fluoroquinolones and beta‐lactams on the in vitro activity of other groups of antibiotics in Salmonella spp.. Apmis. 114(7-8). 523–528. 5 indexed citations
9.
Cebrián, Laura, Juan Carlos Rodrı́guez, Isabel Escribano, & Gloria Royo. (2006). In vitro generation of Salmonella spp. mutants following repeated exposure to β-lactam antibiotics. Journal of Infection and Chemotherapy. 12(2). 80–82. 2 indexed citations
10.
Cebrián, Laura, Isabel Escribano, José C. Rodríguez‐Rey, & Gloria Royo. (2006). Alterations in thegyrA andparC Genes inSalmonellaspp. FollowingIn VitroExposure to Fluoroquinolones. Journal of Chemotherapy. 18(3). 250–254. 1 indexed citations
11.
Yagüe, Alberto, Laura Cebrián, Juan Carlos Rodrı́guez, et al.. (2005). Cepas de Escherichia coli productoras de betalactamasas de espectro extendido: origen, características e incidencia en el sur de la provincia de Alicante en el período 1999-2003. Enfermedades Infecciosas y Microbiología Clínica. 23(2). 76–79. 11 indexed citations
12.
Cebrián, Laura, et al.. (2005). Influence of various criteria for elimination of duplicates when calculating the prevalence and antibiotic susceptibility of microorganisms associated with urinary infections. International Journal of Antimicrobial Agents. 25(2). 173–176. 7 indexed citations
13.
Rodrı́guez, Juan Carlos, et al.. (2005). Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration. International Journal of Antimicrobial Agents. 25(3). 221–225. 9 indexed citations
14.
Cebrián, Laura, Juan Carlos Rodrı́guez, Isabel Escribano, & Gloria Royo. (2005). Characterization of <i>Salmonella </i>spp. Mutants with Reduced Fluoroquinolone Susceptibility: Importance of Efflux Pump Mechanisms. Chemotherapy. 51(1). 40–43. 16 indexed citations
15.
Rodrı́guez, Juan Carlos, et al.. (2005). Mutant Prevention Concentration of Isoniazid, Rifampicin and Rifabutin against <i>Mycobacterium tuberculosis</i>. Chemotherapy. 51(2-3). 76–79. 3 indexed citations
16.
Escribano, Isabel, Juan Carlos Rodrı́guez, Laura Cebrián, & Gloria Royo. (2004). The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. International Journal of Antimicrobial Agents. 24(5). 428–432. 17 indexed citations
17.
Gutiérrez, Félix, Mar Masiá, Juan Carlos Rodrı́guez, et al.. (2003). Evaluation of the Immunochromatographic Binax NOW Assay for Detection ofStreptococcus pneumoniaeUrinary Antigen in a Prospective Study of Community‐Acquired Pneumonia in Spain. Clinical Infectious Diseases. 36(3). 286–292. 184 indexed citations
18.
Ruiz, M., et al.. (2003). Usefulness of different techniques in the study of the epidemiology of salmonellosis. Apmis. 111(9). 848–856. 10 indexed citations
19.
Cebrián, Laura. (2003). Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones. International Journal of Antimicrobial Agents. 22(2). 134–139. 22 indexed citations
20.
Heras, M. De las, et al.. (1993). Evidence for a type D-like retrovirus in enzootic nasal tumour of sheep. Veterinary Record. 132(17). 441–441. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026